An Improved in Vitro Bioassay for the Study of 5-HT(4) Receptors in the Human Isolated Large Intestinal Circular Muscle

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2000 Apr 26

PMID 10780964

Citations 20

Authors

N H Prins

N P Shankley

N J Welsh

M R Briejer

R A Lefebvre

L M Akkermans

J A Schuurkes

Affiliations

Soon will be listed here.

Abstract

Recently, it was demonstrated that 5-HT induces relaxation of human colon circular muscle through activation of 5-HT(4) receptors and 5-HT(7) receptors. The aim of the current study was to develop a new in vitro bioassay of human colon that would facilitate the pharmacological analysis of 5-HT responses mediated solely by 5-HT(4) receptors. Contracting circular muscle strips with KCl (80 mM) yielded a stable contractile tension and, in contrast to muscarinic cholinoceptor agonists and histamine, a profound reduction of spontaneous contractility. This allowed the establishment of reproducible, fully-defined, agonist concentration-response curves by cumulative dosing. Under these conditions, 5-HT induced a concentration-dependent relaxation (pEC(50) 7.31, Hill slope 0.91). Neither methysergide (10 microM) nor granisetron (1 microM) affected the 5-HT-induced relaxation, suggesting that 5-HT(1), 5-HT(2), 5-HT(3), 5-ht(5), 5-HT(6) or 5-HT(7) receptors are not involved. The lack of effect of tetrodotoxin (0.3 microM) indicated a direct effect of 5-HT on the smooth muscle. The selective 5-HT(4) receptor antagonists GR 113808, GR 125487 and RS 39604 competitively antagonized the 5-HT-induced relaxation (pK(B) 9.43, 10.12 and 8.53, respectively). SB 204070 (1 nM) produced a rightward shift (pA(2) 10.34) and depression of the 5-HT curve. These affinity estimates are similar to those previously reported for 5-HT(4) receptors. The selective 5-HT(4) receptor agonists, prucalopride and R076186, induced relaxations (pEC(50) 7.50 and 7.57, respectively), that were blocked by GR 113808 (3 nM), yielding pA(2) estimates of 9.31 and 9.21, respectively. To summarise, in KCl (80 mM)-contracted muscle strips, 5-HT induces relaxation through activation of a homogeneous smooth muscle 5-HT(4) receptor population. This new bioassay allows the focused, pharmacological characterization of human colonic 5-HT(4) receptors in vitro.

Citing Articles

Protective actions of a luminally acting 5-HT receptor agonist in mouse models of colitis.

Hurd M, Haag M, Kwasnik M, Wykosky J, Lavoie B, Mawe G Neurogastroenterol Motil. 2023; 35(11):e14673.

PMID: 37831752 PMC: 10840927. DOI: 10.1111/nmo.14673.

The enteric nervous system.

Sharkey K, Mawe G Physiol Rev. 2022; 103(2):1487-1564.

PMID: 36521049 PMC: 9970663. DOI: 10.1152/physrev.00018.2022.

Current Opinion on Prucalopride in Gastroparesis and Chronic Constipation Treatment: A Focus on Patient Selection and Safety.

Hong J Ther Clin Risk Manag. 2021; 17:601-615.

PMID: 34135588 PMC: 8197617. DOI: 10.2147/TCRM.S269330.

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.

PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.

Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias.

Giudicessi J, Ackerman M, Camilleri M Neurogastroenterol Motil. 2018; 30(6):e13302.

PMID: 29441683 PMC: 6364982. DOI: 10.1111/nmo.13302.

References

Prins N, Briejer M, Van Bergen P, Akkermans L, Schuurkes J . Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle. Br J Pharmacol. 1999; 128(4):849-52. PMC: 1571702. DOI: 10.1038/sj.bjp.0702762. View

ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View

Black J, Leff P, Shankley N . Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol. 1985; 86(3):581-7. PMC: 1916720. DOI: 10.1111/j.1476-5381.1985.tb08934.x. View

Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J . A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol. 1988; 34(6):880-7. View

Sanger G, Nelson D . Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron). Eur J Pharmacol. 1989; 159(2):113-24. DOI: 10.1016/0014-2999(89)90695-x. View

Briejer M, Akkermans L, Meulemans A, Lefebvre R, Schuurkes J . Cisapride and a structural analogue, R 76,186, are 5-hydroxytryptamine4 (5-HT4) receptor agonists on the guinea-pig colon ascendens. Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(5):464-70. DOI: 10.1007/BF00166736. View

Grossman C, Kilpatrick G, Bunce K . Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol. 1993; 109(3):618-24. PMC: 2175660. DOI: 10.1111/j.1476-5381.1993.tb13617.x. View

Kaumann A . Blockade of human atrial 5-HT4 receptors by GR 113808. Br J Pharmacol. 1993; 110(3):1172-4. PMC: 2175795. DOI: 10.1111/j.1476-5381.1993.tb13937.x. View

Borman R, Burleigh D . Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT. Br J Pharmacol. 1993; 110(3):927-8. PMC: 2175779. DOI: 10.1111/j.1476-5381.1993.tb13901.x. View

10.

Gale J, Grossman C, Whitehead J, Oxford A, Bunce K, Humphrey P . GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol. 1994; 111(1):332-8. PMC: 1910004. DOI: 10.1111/j.1476-5381.1994.tb14064.x. View

11.

Kaumann A, Gaster L, King F, Brown A . Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(5):546-8. DOI: 10.1007/BF00169146. View

12.

Wardle K, Ellis E, Baxter G, Kennett G, Gaster L, Sanger G . The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol. 1994; 112(3):789-94. PMC: 1910219. DOI: 10.1111/j.1476-5381.1994.tb13148.x. View

13.

Tam F, Hillier K, Bunce K . Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle. Br J Pharmacol. 1994; 113(1):143-50. PMC: 1510073. DOI: 10.1111/j.1476-5381.1994.tb16186.x. View

14.

Reynolds G, Mason S, Meldrum A, de Keczer S, Parnes H, Eglen R . 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br J Pharmacol. 1995; 114(5):993-8. PMC: 1510307. DOI: 10.1111/j.1476-5381.1995.tb13303.x. View

15.

Tam F, Hillier K, Bunce K, Grossman C . Differences in response to 5-HT4 receptor agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle. Br J Pharmacol. 1995; 115(1):172-6. PMC: 1908740. DOI: 10.1111/j.1476-5381.1995.tb16335.x. View

16.

McLean P, Coupar I, Molenaar P . A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum. Br J Pharmacol. 1995; 115(1):47-56. PMC: 1908741. DOI: 10.1111/j.1476-5381.1995.tb16318.x. View

17.

Leung E, Blissard D, Jett M, Eglen R . Investigation of the 5-hydroxytryptamine receptor mediating the "transient" short-circuit current response in guinea-pig ileal mucosa. Naunyn Schmiedebergs Arch Pharmacol. 1995; 351(6):596-602. DOI: 10.1007/BF00170158. View

18.

McLean P, Coupar I . 5-HT4 receptor antagonist affinities of SB207710, SB205008, and SB203186 in the human colon, rat oesophagus, and guinea-pig ileum peristaltic reflex. Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(2):132-40. DOI: 10.1007/BF00176766. View

19.

Kuemmerle J, Murthy K, Grider J, Martin D, Makhlouf G . Coexpression of 5-HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells. Gastroenterology. 1995; 109(6):1791-800. DOI: 10.1016/0016-5085(95)90745-9. View

20.

Hegde S, Bonhaus D, Johnson L, Leung E, Clark R, Eglen R . RS 39604: a potent, selective and orally active 5-HT4 receptor antagonist. Br J Pharmacol. 1995; 115(6):1087-95. PMC: 1908997. DOI: 10.1111/j.1476-5381.1995.tb15922.x. View